Evidence map›Paper›PMID 38786752›Full record

ArticleMetabolites2024

NMR Precision Metabolomics: Dynamic Peak Sum Thresholding and Navigators for Highly Standardized and Reproducible Metabolite Profiling of Clinical Urine Samples.

Alessia Trimigno, Nicole R Holderman, Chen Dong, Kari D Boardman, Jifang Zhao, Elizabeth M O'Day

Abstract read
In one paragraph

Article in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. QuantitativeMolecules (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Metabolic Profile of Senegalese Sole (Molecules (Basel, Switzerland) · 2025
    Article
  4. Investigation of pH-dependentInternational journal of obesity (2005) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessia TrimignoOlaris, Inc., Framingham, MA 01702, USA.ORCID 0000-0003-3154-2198
Nicole R HoldermanOlaris, Inc., Framingham, MA 01702, USA.
Chen DongOlaris, Inc., Framingham, MA 01702, USA.
Kari D BoardmanOlaris, Inc., Framingham, MA 01702, USA.
Jifang ZhaoOlaris, Inc., Framingham, MA 01702, USA.
Elizabeth M O'DayOlaris, Inc., Framingham, MA 01702, USA.ORCID 0000-0001-5854-9029

Funding

Olaris, Inc NA
6 · The paper itself

Abstract

Metabolomics, especially urine-based studies, offers incredible promise for the discovery and development of clinically impactful biomarkers. However, due to the unique challenges of urine, a highly precise and reproducible workflow for NMR-based urine metabolomics is lacking. Using 1D and 2D non-uniform sampled (NUS)

Indexed as

metabolomicsNMRurinary biomarkers

Identifiers

PMID38786752
PMCPMC11122845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.